Playback speed
10 seconds
Novel Treatment Options for High-Risk/Eldery AML Patients: CPX-351, Glasdegib + LDAC & Venetoclax + Hypomethylating Agents
150 views
July 19, 2019
Login to view comments.
Click here to Login